Kevin C. Gorman
2019
Compensation breakdown
| Bonus | $667,000 |
|---|---|
| Option Awards | $6,000,525 |
| Salary | $725,000 |
| Stock Awards | $2,000,071 |
| Other | $58,230 |
| Total | $9,450,826 |
Gorman received $6M in option awards, accounting for 63% of the total pay in 2019.
Gorman also received $667K in bonus, $725K in salary, $2M in stock awards and $58.2K in other compensation.
Rankings
In 2019, Kevin C. Gorman's compensation ranked 823rd out of 13,971 executives tracked by ExecPay. In other words, Gorman earned more than 94.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 823 out of 13,971 | 94th |
Division Manufacturing | 287 out of 5,698 | 95th |
Major group Chemicals And Allied Products | 81 out of 2,197 | 96th |
Industry group Drugs | 67 out of 1,883 | 96th |
Industry Biological Products, Except Diagnostic Substances | 12 out of 389 | 97th |
Pay ratio
| Kevin C. Gorman's Pay | $9,450,826 |
|---|---|
| Median Employee's Pay | $257,209 |
| Pay Ratio | 37to 1 |
In 2019, the annual total compensation of Kevin C. Gorman was $9,450,826.
The annual total compensation of the median employee at Neurocrine Biosciences was $257,209.
The ratio of Kevin C. Gorman's pay to the pay of median employee was therefore 37 to one.
Gorman's colleagues
We found five more compensation records of executives who worked with Kevin C. Gorman at Neurocrine Biosciences in 2019.
2019
Matthew Abernethy
Neurocrine Biosciences
Chief Financial Officer
2019
Eric Benevich
Neurocrine Biosciences
Chief Commercial Officer
2019
Eiry Roberts
Neurocrine Biosciences
Chief Medical Officer
2019
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
2019
Kyle Gano
Neurocrine Biosciences
Chief Development and Strategy Officer
News
April 7, 2022
April 9, 2021
April 9, 2020
April 17, 2019